MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.thromres.2014.02.004

Медицинская библиотека · Thrombosis research · 2014

Tamoxifen induces resistance to activated protein C.

Rühl Heiko, Schröder Lars, Müller Jens, Fimmers Rolf, Sukhitashvili Shorena, Welz Julia, Kuhn Walther C, Oldenburg Johannes, Rudlowski Christian, Pötzsch Bernd

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

The estrogen antagonist tamoxifen (TAM) increases the thrombotic risk similar to estrogen containing oral contraceptives (OC). In OC users this risk is attributed to alterations of hemostasis resulting in acquired resistance to activated protein C (APC). TAM-induced APC resistance has not been reported yet.

MATERIALS AND

METHODS

Blood samples were collected prospectively from women with breast cancer before (n=25) and monthly after start of adjuvant TAM treatment (n=75). APC resistance was evaluated on basis of the effect of APC on the endogenous thrombin generation potential. To detect increased in vivo APC generation APC plasma levels were measured using a highly sensitive oligonucleotide-based enzyme capture assay. Routine hemostasis parameters were measured additionally.

RESULTS

APC sensitivity decreased by 41% (p=0.001) compared to baseline after one month of TAM application and remained significantly decreased during the study period. Free protein S increased (p=0.008) while other analyzed procoagulant factors, inhibitors, and activation markers of coagulation decreased or did not change significantly. In five patients the APC concentration increased to non-physiological levels but an overall significant increase of APC was not observed.

CONCLUSIONS

This is the first study showing acquired APC resistance under TAM therapy. Acquired APC resistance might explain the increased thrombotic risk during TAM treatment. Observed changes of hemostasis parameters suggest different determinants of TAM-induced APC resistance than in OC-induced APC resistance. The presence of acquired APC resistance in TAM patients warrants further evaluation if these patients may benefit from antithrombotic prophylaxis in the presence of additional thrombotic risk factors.

Для цитирования: Rühl Heiko, Schröder Lars, Müller Jens, Fimmers Rolf, Sukhitashvili Shorena, Welz Julia, Kuhn Walther C, Oldenburg Johannes, Rudlowski Christian, Pötzsch Bernd. Tamoxifen induces resistance to activated protein C.. Thrombosis research. 2014. DOI: 10.1016/j.thromres.2014.02.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.